Prompt Cast
"Phil's Struggle with Diabetes Drug Affordability in the Age of Shortage."
Generated on February 14, 2026
TLDR In Planet Money's latest episode, Phil shares his transformative yet financially strained experience with the costly diabetes drug Ozempic; meanwhile, Chris Spears starts Orderly Meds to navigate obesity medication shortages and legal hurdles.
Timestamped Summary
00:00
Phil's transformative journey from addiction and pre-diabetes, facilitated by the life-changing but expensive drug Ozempic, highlighted in Planet Money.
04:11
Phil's life was turned around with an expensive diabetes drug until he couldn't afford it after a switch in insurance. He now grapples with the temptation of cheaper, unregulated alternatives online.
08:04
Phil grapples with affordability of his diabetes medication after insurance changes.
11:51
Phil grapples with the rising costs of his diabetes medication due to insurance changes.
15:26
Chris capitalized on the obesity drug demand surge by launching Orderly Meds in January 2024 as a telehealth intermediary between pharmacies and patients, rapidly scaling to over 50,00CT customers.
19:08
Chris Spears capitalized by creating telehealth intermediary Orderly Meds to supply semaglutide for Ozempic production during an obesity drug shortage, leveraging a legal gray market with variable regulations and oversight.
23:19
Amidst drug shortages and FDA reaffirmations that obesity medication production met demand, Chris Spears' telehealth intermediary Orderly Meds explored customizing weight loss drugs while facing legal challenges.
27:08
Amidst drug shortages and amid growing demand, Chris Spears of a telehealth company that customizes weight loss drugs faces legal challenges from brand name manufacturers.
31:07
Amidst drug shortages, Chris opts for affordable off-brand weight loss drugs but faces legal risks and potential health hazards from unverified sources.
